The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Therapy and Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cancer Detection
1.2.3 Cancer Treatment
1.3 Market by Application
1.3.1 Global Cancer Therapy and Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Lung Cancer
1.3.3 Rectal Cancer
1.3.4 Breast Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Therapy and Testing Market Perspective (2018-2029)
2.2 Cancer Therapy and Testing Growth Trends by Region
2.2.1 Global Cancer Therapy and Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cancer Therapy and Testing Historic Market Size by Region (2018-2023)
2.2.3 Cancer Therapy and Testing Forecasted Market Size by Region (2024-2029)
2.3 Cancer Therapy and Testing Market Dynamics
2.3.1 Cancer Therapy and Testing Industry Trends
2.3.2 Cancer Therapy and Testing Market Drivers
2.3.3 Cancer Therapy and Testing Market Challenges
2.3.4 Cancer Therapy and Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Therapy and Testing Players by Revenue
3.1.1 Global Top Cancer Therapy and Testing Players by Revenue (2018-2023)
3.1.2 Global Cancer Therapy and Testing Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Therapy and Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Therapy and Testing Revenue
3.4 Global Cancer Therapy and Testing Market Concentration Ratio
3.4.1 Global Cancer Therapy and Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Therapy and Testing Revenue in 2022
3.5 Cancer Therapy and Testing Key Players Head office and Area Served
3.6 Key Players Cancer Therapy and Testing Product Solution and Service
3.7 Date of Enter into Cancer Therapy and Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Therapy and Testing Breakdown Data by Type
4.1 Global Cancer Therapy and Testing Historic Market Size by Type (2018-2023)
4.2 Global Cancer Therapy and Testing Forecasted Market Size by Type (2024-2029)
5 Cancer Therapy and Testing Breakdown Data by Application
5.1 Global Cancer Therapy and Testing Historic Market Size by Application (2018-2023)
5.2 Global Cancer Therapy and Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cancer Therapy and Testing Market Size (2018-2029)
6.2 North America Cancer Therapy and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cancer Therapy and Testing Market Size by Country (2018-2023)
6.4 North America Cancer Therapy and Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Therapy and Testing Market Size (2018-2029)
7.2 Europe Cancer Therapy and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cancer Therapy and Testing Market Size by Country (2018-2023)
7.4 Europe Cancer Therapy and Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Therapy and Testing Market Size (2018-2029)
8.2 Asia-Pacific Cancer Therapy and Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cancer Therapy and Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Cancer Therapy and Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Therapy and Testing Market Size (2018-2029)
9.2 Latin America Cancer Therapy and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cancer Therapy and Testing Market Size by Country (2018-2023)
9.4 Latin America Cancer Therapy and Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Therapy and Testing Market Size (2018-2029)
10.2 Middle East & Africa Cancer Therapy and Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cancer Therapy and Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Cancer Therapy and Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Invitae
11.1.1 Invitae Company Detail
11.1.2 Invitae Business Overview
11.1.3 Invitae Cancer Therapy and Testing Introduction
11.1.4 Invitae Revenue in Cancer Therapy and Testing Business (2018-2023)
11.1.5 Invitae Recent Development
11.2 Foundation Medicine
11.2.1 Foundation Medicine Company Detail
11.2.2 Foundation Medicine Business Overview
11.2.3 Foundation Medicine Cancer Therapy and Testing Introduction
11.2.4 Foundation Medicine Revenue in Cancer Therapy and Testing Business (2018-2023)
11.2.5 Foundation Medicine Recent Development
11.3 Guardant Health
11.3.1 Guardant Health Company Detail
11.3.2 Guardant Health Business Overview
11.3.3 Guardant Health Cancer Therapy and Testing Introduction
11.3.4 Guardant Health Revenue in Cancer Therapy and Testing Business (2018-2023)
11.3.5 Guardant Health Recent Development
11.4 Illumina
11.4.1 Illumina Company Detail
11.4.2 Illumina Business Overview
11.4.3 Illumina Cancer Therapy and Testing Introduction
11.4.4 Illumina Revenue in Cancer Therapy and Testing Business (2018-2023)
11.4.5 Illumina Recent Development
11.5 Sysmex
11.5.1 Sysmex Company Detail
11.5.2 Sysmex Business Overview
11.5.3 Sysmex Cancer Therapy and Testing Introduction
11.5.4 Sysmex Revenue in Cancer Therapy and Testing Business (2018-2023)
11.5.5 Sysmex Recent Development
11.6 Abingdon Health
11.6.1 Abingdon Health Company Detail
11.6.2 Abingdon Health Business Overview
11.6.3 Abingdon Health Cancer Therapy and Testing Introduction
11.6.4 Abingdon Health Revenue in Cancer Therapy and Testing Business (2018-2023)
11.6.5 Abingdon Health Recent Development
11.7 Sophia
11.7.1 Sophia Company Detail
11.7.2 Sophia Business Overview
11.7.3 Sophia Cancer Therapy and Testing Introduction
11.7.4 Sophia Revenue in Cancer Therapy and Testing Business (2018-2023)
11.7.5 Sophia Recent Development
11.8 NanoEntek
11.8.1 NanoEntek Company Detail
11.8.2 NanoEntek Business Overview
11.8.3 NanoEntek Cancer Therapy and Testing Introduction
11.8.4 NanoEntek Revenue in Cancer Therapy and Testing Business (2018-2023)
11.8.5 NanoEntek Recent Development
11.9 BGI
11.9.1 BGI Company Detail
11.9.2 BGI Business Overview
11.9.3 BGI Cancer Therapy and Testing Introduction
11.9.4 BGI Revenue in Cancer Therapy and Testing Business (2018-2023)
11.9.5 BGI Recent Development
11.10 Diagnosis
11.10.1 Diagnosis Company Detail
11.10.2 Diagnosis Business Overview
11.10.3 Diagnosis Cancer Therapy and Testing Introduction
11.10.4 Diagnosis Revenue in Cancer Therapy and Testing Business (2018-2023)
11.10.5 Diagnosis Recent Development
11.11 Exact Sciences
11.11.1 Exact Sciences Company Detail
11.11.2 Exact Sciences Business Overview
11.11.3 Exact Sciences Cancer Therapy and Testing Introduction
11.11.4 Exact Sciences Revenue in Cancer Therapy and Testing Business (2018-2023)
11.11.5 Exact Sciences Recent Development
11.12 AstraZeneca
11.12.1 AstraZeneca Company Detail
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Cancer Therapy and Testing Introduction
11.12.4 AstraZeneca Revenue in Cancer Therapy and Testing Business (2018-2023)
11.12.5 AstraZeneca Recent Development
11.13 Bayer AG
11.13.1 Bayer AG Company Detail
11.13.2 Bayer AG Business Overview
11.13.3 Bayer AG Cancer Therapy and Testing Introduction
11.13.4 Bayer AG Revenue in Cancer Therapy and Testing Business (2018-2023)
11.13.5 Bayer AG Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Detail
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Cancer Therapy and Testing Introduction
11.14.4 Johnson & Johnson Revenue in Cancer Therapy and Testing Business (2018-2023)
11.14.5 Johnson & Johnson Recent Development
11.15 Pfizer Inc.
11.15.1 Pfizer Inc. Company Detail
11.15.2 Pfizer Inc. Business Overview
11.15.3 Pfizer Inc. Cancer Therapy and Testing Introduction
11.15.4 Pfizer Inc. Revenue in Cancer Therapy and Testing Business (2018-2023)
11.15.5 Pfizer Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details